BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16445063)

  • 1. [Correction of the glicemia level in elderly and senile patients with diabetes mellitus, operated for purulent-necrotic foot lesion].
    Ivashchenko VV; Kolkin Iag; Koval'chuk VS; Ivashchenko AV
    Klin Khir; 2005 Aug; (8):51-4. PubMed ID: 16445063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes of the glycemia level in surgical treatment of purulent-necrotic affection of the foot in patients with diabetes mellitus].
    Podpriatov SIe; Shcherbak OV; Pkhakadze OH; Skybun VM; Harbarchuk OI
    Klin Khir; 2000 Dec; (12):45-6. PubMed ID: 11247490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of prostaglandin E1 and systemic antibacterial therapy application in patients with diabetes mellitus and purulent-necrotic lesions of the foot].
    Podpriatov SIe; Hrabovyĭ OM; Salata VV; Zaĭtsev SV; Simonova ZIe; Korbut SM; Shyshova SIa; Rohacheva VP
    Klin Khir; 2010; (11-12):76-8. PubMed ID: 21268804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical treatment of purulent necrotic complications in patients with diabetic foot syndrome].
    Datsenko BM; Belov SG; Girka EI
    Klin Khir; 2001 Aug; (8):10-2. PubMed ID: 11794095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tactics of surgical treatment of suppurative-necrotic lesions of the foot and leg in patients with diabetes mellitus].
    Isaev GB; Guseĭnov SA
    Khirurgiia (Mosk); 1996; (2):90-1. PubMed ID: 8754914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of vascular therapy in complex of treatment of purulent necrotic foot ulcers in patients with diabetes mellitus].
    Podpriatov SIe; Lisovets' VV; Huch AO; Tovkun VK; Slobodeniuk IM; Hupalo IuM
    Klin Khir; 2001 Feb; (2):27-9. PubMed ID: 11482020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purulent and necrotic complications of diabetic foot syndrome and their reflection in ICD-10 and standards of insurance medicine].
    Briskin BS; Dibirov MD; Khamiitov FF; Proshin AV; Iakovishvili IaI
    Khirurgiia (Mosk); 2007; (1):49-54. PubMed ID: 17426690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prolonged intraarterial medicinal therapy of the destructive forms of diabetic foot syndrome].
    Antoniuk SM; Sviridov MV; Andrienko IB; Karabak SG; Barkalov SV
    Klin Khir; 2005 Sep; (9):26-8. PubMed ID: 16445040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokine profile and fibrinogen level in blood plasma in diabetic foot under the action of heparin].
    Harbarchuk OI
    Ukr Biokhim Zh (1999); 2000; 72(3):118-9. PubMed ID: 11200464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial therapy of purulent necrotic foot lesions in patients with diabetes mellitus].
    Podpriatov SIe; Larionov HM; Simonova ZIe; Tovkun VK
    Klin Khir; 2001 Aug; (8):42-7. PubMed ID: 11794111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severity of purulent-necrotic process of the foot in diabetes mellitus].
    Narchaev ZhA
    Klin Khir; 2009 Sep; (9):36-7. PubMed ID: 20218402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vast purulent necrotic lesions in patients with diabetes mellitus].
    Liul'ko IB; Kosul'nikov SO; Tarnopolskiĭ SA
    Klin Khir; 2001 Aug; (8):28-30. PubMed ID: 11794104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
    Svetukhin AM; Zemlianoĭ AB; Orudzheva SA; Titova MI; Rudneva VG; Elagina LV; Pavlova MV; Terekhova RP; Bozh'eva EI; Makhmudova LS
    Ter Arkh; 2001; 73(4):31-3. PubMed ID: 11494443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes in the elderly, Part II. Finding the balance for drug therapy.
    Cirone N; Schwartz N
    Nursing; 1996 Mar; 26(3):40-5; quiz 46-7. PubMed ID: 8700471
    [No Abstract]   [Full Text] [Related]  

  • 15. [Restorative operations on main vessels for diabetic angiopathy of lower extremities with purulent-necrotic complications].
    Shor NA; Chumak IuF; Reuka VP; Zhukov OA
    Klin Khir; 2003 Sep; (9):20-2. PubMed ID: 14663904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of purulent and necrotic lesions of the lower extremities in patients with diabetes mellitus].
    Ohonovsky? VK; Podil?hak MD; Matskiv AS; Kravets SL; Tsemekhin BD
    Klin Khir (1962); 1993; (9-10):37-40. PubMed ID: 8158919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of lumbar sympathectomy for the lower extremities diabetic angiopathy in presence of purulent necrotic changes on the foot].
    Shor NA; Chumak IuF
    Klin Khir; 2001 Aug; (8):59-61. PubMed ID: 11794119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological justification of the effectiveness of ultrasonic cavitation with 0.2].
    Chekmareva IA; Blatun LA; Paskhalova YS; Mitish VA; Paklina OV; Terekhova RP; Sepeda P; Magomedova SD; Ushakov AA; Sokov SL
    Khirurgiia (Mosk); 2019; (7):63-70. PubMed ID: 31355817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary syndrome in patients with diabetic foot].
    Mazurok LM
    Klin Khir; 2001 Aug; (8):32-3. PubMed ID: 11794106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arfazetin in the treatment of diabetes mellitus].
    Korotkova VD; Perelygina AA; Trumpe TE; Sokolov SIa; Lobanova AM
    Probl Endokrinol (Mosk); 1988; 34(4):25-8. PubMed ID: 3057485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.